Diverse effects of Porphyromonas gingivalis on human osteoclast formation

Microbial Pathogenesis

Volumn 51, Issue 3, 2011, Pages 149-155

  Scheres, Nina ^a,b   de Vries, Teun J ^b   Brunner, Jorg ^a   Crielaard, Wim ^a   Laine, Marja L ^b   Everts, Vincent ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Gingival fibroblast; LPS; Pro inflammatory cytokines; RANKL and M CSF; TRACP positive

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BACTERIUM LIPOPOLYSACCHARIDE; COLONY STIMULATING FACTOR 1; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; POLYMYXIN B;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIABILITY; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FEMALE; FIBROBLAST; GENE EXPRESSION REGULATION; GINGIVA; GRAM NEGATIVE INFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MALE; NONHUMAN; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOLYSIS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; FEMALE; FIBROBLASTS; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; OSTEOCLASTS; PORPHYROMONAS GINGIVALIS; RANK LIGAND; STEM CELLS; YOUNG ADULT;

BACTERIA (MICROORGANISMS); PORPHYROMONAS GINGIVALIS;

EID: 79959366328     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2011.04.006     Document Type: Article

References (66)

1. Darveau R.P. The oral microbial consortium's interaction with the periodontal innate defense system. DNA Cell Biol 2009, 28(8):389-395.
2. Socransky S.S., Haffajee A.D., Cugini M.A., Smith C., Kent R.L. Microbial complexes in subgingival plaque. J Clin Periodontol 1998, 25(2):134-144.
3. Brunner J., Scheres N., El Idrissi N.B., Deng D.M., Laine M.L., van Winkelhoff A.J., et al. The capsule of Porphyromonas gingivalis reduces the immune response of human gingival fibroblasts. BMC Microbiol 2010, 10:5.
4. Laine M.L., Appelmelk B.J., van Winkelhoff A.J. Prevalence and distribution of six capsular serotypes of Porphyromonas gingivalis in periodontitis patients. J Dent Res 1997, 76(12):1840-1844.
5. O'Brien-Simpson N.M., Veith P.D., Dashper S.G., Reynolds E.C. Antigens of bacteria associated with periodontitis. Periodontol 2000, 2004(35):101-134.
6. Pathirana R.D., O'Brien-Simpson N.M., Reynolds E.C. Host immune responses to Porphyromonas gingivalis antigens. Periodontol 2000 2010, 52(1):218-237.
7. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999, 20(3):345-357.
8. Lee S.K., Lorenzo J. Cytokines regulating osteoclast formation and function. Curr Opin Rheumatol 2006, 18(4):411-418.
9. Boyce B.F., Yao Z., Xing L. Functions of nuclear factor kappaB in bone. Ann N Y Acad Sci 2010, 1192(1):367-375.
10. Chambers T.J. Regulation of the differentiation and function of osteoclasts. J Pathol 2000, 192(1):4-13.
11. Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol 2008, 79(8 Suppl):1585-1591.
12. Graves D.T., Oskoui M., Volejnikova S., Naguib G., Cai S., Desta T., et al. Tumor necrosis factor modulates fibroblast apoptosis, PMN recruitment, and osteoclast formation in response to P. gingivalis infection. J Dent Res 2001, 80(10):1875-1879.
13. Kinane D.F., Mark Bartold P. Clinical relevance of the host responses of periodontitis. Periodontol 2000 2007, 43:278-293.
14. Liu Y.C., Lerner U.H., Teng Y.T. Cytokine responses against periodontal infection: protective and destructive roles. Periodontol 2000 2010, 52(1):163-206.
15. Taubman M.A., Valverde P., Han X., Kawai T. Immune response: the key to bone resorption in periodontal disease. J Periodontol 2005, 76(11 Suppl):2033-2041.
16. Okahashi N., Inaba H., Nakagawa I., Yamamura T., Kuboniwa M., Nakayama K., et al. Porphyromonas gingivalis induces receptor activator of NF-kappaB ligand expression in osteoblasts through the activator protein 1 p.thway. Infect Immun 2004, 72(3):1706-1714.
17. Reddi D., Bostanci N., Hashim A., Aduse-Opoku J., Curtis M.A., Hughes F.J., et al. Porphyromonas gingivalis regulates the RANKL-OPG system in bone marrow stromal cells. Microbes Infect 2008, 10(14-15):1459-1468.
18. Scheres N., Laine M.L., de Vries T.J., Everts V., van Winkelhoff A.J. Gingival and periodontal ligament fibroblasts differ in their inflammatory response to viable Porphyromonas gingivalis. J Periodontal Res 2010, 45(2):262-270.
19. Belibasakis G.N., Bostanci N., Hashim A., Johansson A., Aduse-Opoku J., Curtis M.A., et al. Regulation of RANKL and OPG gene expression in human gingival fibroblasts and periodontal ligament cells by Porphyromonas gingivalis: a putative role of the Arg-gingipains. Microb Pathog 2007, 43(1):46-53.
20. Belibasakis G.N., Reddi D., Bostanci N. Porphyromonas gingivalis Induces RANKL in T-cells. Inflammation 2010.
21. Kim N., Kadono Y., Takami M., Lee J., Lee S.H., Okada F., et al. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med 2005, 202(5):589-595.
22. Kobayashi K., Takahashi N., Jimi E., Udagawa N., Takami M., Kotake S., et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 2000, 191(2):275-286.
23. Fuller K., Murphy C., Kirstein B., Fox S.W., Chambers T.J. TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 2002, 143(3):1108-1118.
24. Azuma Y., Kaji K., Katogi R., Takeshita S., Kudo A. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem 2000, 275(7):4858-4864.
25. Kim M.S., Day C.J., Selinger C.I., Magno C.L., Stephens S.R., Morrison N.A. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption. J Biol Chem 2006, 281(2):1274-1285.
26. Kim M.S., Magno C.L., Day C.J., Morrison N.A. Induction of chemokines and chemokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP-1 and RANTES. J Cell Biochem 2006, 97(3):512-518.
27. Yu X., Huang Y., Collin-Osdoby P., Osdoby P. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. J Bone Miner Res 2004, 19(12):2065-2077.
28. Bendre M.S., Montague D.C., Peery T., Akel N.S., Gaddy D., Suva L.J. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone 2003, 33(1):28-37.
29. Chen L.L., Yan J. Porphyromonas gingivalis lipopolysaccharide activated bone resorption of osteoclasts by inducing IL-1, TNF, and PGE. Acta Pharmacol Sin 2001, 22(7):614-618.
30. Eskan M.A., Hajishengallis G., Kinane D.F. Differential activation of human gingival epithelial cells and monocytes by Porphyromonas gingivalis fimbriae. Infect Immun 2007, 75(2):892-898.
31. Mahanonda R., Sa-Ard-Iam N., Charatkulangkun O., Promsudthi A., Schifferle R.E., Yongvanichit K., et al. Monocyte activation by Porphyromonas gingivalis LPS in aggressive periodontitis with the use of whole-blood cultures. J Dent Res 2004, 83(7):540-545.
32. Uehara A., Imamura T., Potempa J., Travis J., Takada H. Gingipains from Porphyromonas gingivalis synergistically induce the production of proinflammatory cytokines through protease-activated receptors with Toll-like receptor and NOD1/2 ligands in human monocytic cells. Cell Microbiol 2008, 10(5):1181-1189.
33. Zhang D., Chen L., Li S., Yan J. Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1b, TNFa and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS. Innate Immun 2008, 14(2):99-107.
34. Ara T., Kurata K., Hirai K., Uchihashi T., Uematsu T., Imamura Y., et al. Human gingival fibroblasts are critical in sustaining inflammation in periodontal disease. J Periodontal Res 2009, 44(1):21-27.
35. Buckley C.D., Pilling D., Lord J.M., Akbar A.N., Scheel-Toellner D., Salmon M. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol 2001, 22(4):199-204.
36. Flavell S.J., Hou T.Z., Lax S., Filer A.D., Salmon M., Buckley C.D. Fibroblasts as novel therapeutic targets in chronic inflammation. Br J Pharmacol 2008, 153(Suppl 1):S241-S246.
37. de Vries T.J., Schoenmaker T., Wattanaroonwong N., van den Hoonaard M., Nieuwenhuijse A., Beertsen W., et al. Gingival fibroblasts are better at inhibiting osteoclast formation than periodontal ligament fibroblasts. J Cell Biochem 2006, 98(2):370-382.
38. Jiang Y., Mehta C.K., Hsu T.Y., Alsulaimani F.F. Bacteria induce osteoclastogenesis via an osteoblast-independent pathway. Infect Immun 2002, 70(6):3143-3148.
39. Grenier D., Mayrand D. Functional characterization of extracellular vesicles produced by Bacteroides gingivalis. Infect Immun 1987, 55(1):111-117.
40. Kuehn M.J., Kesty N.C. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev 2005, 19(22):2645-2655.
41. Zhou L., Srisatjaluk R., Justus D.E., Doyle R.J. On the origin of membrane vesicles in gram-negative bacteria. FEMS Microbiol Lett 1998, 163(2):223-228.
42. Yamaguchi M., Ukai T., Kaneko T., Yoshinaga M., Yokoyama M., Ozaki Y., et al. T cells are able to promote lipopolysaccharide-induced bone resorption in mice in the absence of B cells. J Periodontal Res 2008, 43(5):549-555.
43. Kawai T., Matsuyama T., Hosokawa Y., Makihira S., Seki M., Karimbux N.Y., et al. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol 2006, 169(3):987-998.
44. Yasuhara R., Miyamoto Y., Takami M., Imamura T., Potempa J., Yoshimura K., et al. Lysine-specific gingipain promotes lipopolysaccharide- and active-vitamin D3-induced osteoclast differentiation by degrading osteoprotegerin. Biochem J 2009, 419(1):159-166.
45. Steffen M.J., Holt S.C., Ebersole J.L. Porphyromonas gingivalis induction of mediator and cytokine secretion by human gingival fibroblasts. Oral Microbiol Immunol 2000, 15(3):172-180.
46. Ukai T., Yumoto H., Gibson F.C., Genco C.A. Macrophage-elicited osteoclastogenesis in response to bacterial stimulation requires Toll-like receptor 2-dependent tumor necrosis factor-alpha production. Infect Immun 2008, 76(2):812-819.
47. Zou W., Bar-Shavit Z. Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res 2002, 17(7):1211-1218.
48. Fujimura Y., Hotokezaka H., Ohara N., Naito M., Sakai E., Yoshimura M., et al. The hemoglobin receptor protein of Porphyromonas gingivalis inhibits receptor activator NF-kappaB ligand-induced osteoclastogenesis from bone marrow macrophages. Infect Immun 2006, 74(5):2544-2551.
49. Choi B.K., Moon S.Y., Cha J.H., Kim K.W., Yoo Y.J. Prostaglandin E(2) is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii. J Periodontol 2005, 76(5):813-820.
50. Suda K., Woo J.T., Takami M., Sexton P.M., Nagai K. Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL. J Cell Physiol 2002, 190(1):101-108.
51. Balga R., Wetterwald A., Portenier J., Dolder S., Mueller C., Hofstetter W. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro. Bone 2006, 39(2):325-335.
52. Zou W., Schwartz H., Endres S., Hartmann G., Bar-Shavit Z. CpG oligonucleotides: novel regulators of osteoclast differentiation. FASEB J 2002, 16(3):274-282.
53. Ji J.D., Park-Min K.H., Shen Z., Fajardo R.J., Goldring S.R., McHugh K.P., et al. Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors. J Immunol 2009, 183(11):7223-7233.
54. Nagasawa T., Kobayashi H., Kiji M., Aramaki M., Mahanonda R., Kojima T., et al. LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. Clin Exp Immunol 2002, 130(2):338-344.
55. Takami M., Kim N., Rho J., Choi Y. Stimulation by toll-like receptors inhibits osteoclast differentiation. J Immunol 2002, 169(3):1516-1523.
56. Hajishengallis G. Toll gates to periodontal host modulation and vaccine therapy. Periodontol 2000, 2009(51):181-207.
57. Hajishengallis G., Martin M., Sojar H.T., Sharma A., Schifferle R.E., DeNardin E., et al. Dependence of bacterial protein adhesins on toll-like receptors for proinflammatory cytokine induction. Clin Diagn Lab Immunol 2002, 9(2):403-411.
58. Hajishengallis G., Sharma A., Russell M.W., Genco R.J. Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis. Ann Periodontol 2002, 7(1):72-78.
59. Kikkert R., Laine M.L., Aarden L.A., van Winkelhoff A.J. Activation of toll-like receptors 2 and 4 by gram-negative periodontal bacteria. Oral Microbiol Immunol 2007, 22(3):145-151.
60. O'Mahony D.S., Pham U., Iyer R., Hawn T.R., Liles W.C. Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages. Int J Med Sci 2008, 5(1):1-8.
61. Kiji M., Nagasawa T., Hormdee D., Yashiro R., Kobayashi H., Noguchi K., et al. Internal prostaglandin synthesis augments osteoprotegerin production in human gingival fibroblasts stimulated by lipopolysaccharide. Clin Exp Immunol 2007, 149(2):327-334.
62. Lu H.K., Yeh K.C., Wu M.F., Li C.L., Tseng C.C. An acute injection of Porphyromonas gingivalis lipopolysaccharide modulates the OPG/RANKL system and interleukin-6 in an ovariectomized mouse model. Oral Microbiol Immunol 2008, 23(3):220-225.
63. Goodson J.M., Tanner A.C., Haffajee A.D., Sornberger G.C., Socransky S.S. Patterns of progression and regression of advanced destructive periodontal disease. J Clin Periodontol 1982, 9(6):472-481.
64. Silva N., Dutzan N., Hernandez M., Dezerega A., Rivera O., Aguillon J.C., et al. Characterization of progressive periodontal lesions in chronic periodontitis patients: levels of chemokines, cytokines, matrix metalloproteinase-13, periodontal pathogens and inflammatory cells. J Clin Periodontol 2008, 35(3):206-214.
65. Liljenberg B., Lindhe J., Berglundh T., Dahlen G., Jonsson R. Some microbiological, histopathological and immunohistochemical characteristics of progressive periodontal disease. J Clin Periodontol 1994, 21(10):720-727.
66. Belibasakis G.N., Meier A., Guggenheim B., Bostanci N. Oral biofilm challenge regulates the RANKL-OPG system in periodontal ligament and dental pulp cells. Microb Pathog 2011, 50(1):6-11.